Nanochon

Nanochon

Tags
OrthopedicsMedical DevicesSports Medicine
Website
https://www.nanochon.com/
Cohort
'22-'23 Cohort
  • Description of Project
  • Goals and Rationale for Project
  • Key Metrics and Deliverables
  • Ideal Competencies
  • Nanochon in the News
💡
Nanochon is an early stage medical device company, developing an implant to treat cartilage damage and loss in joints. Focused on arthritis and sports injuries in the knee, the device is a minimally invasive, bioactive patch which can be used to fill and and repair damaged areas of the joint surface, in a minimally invasive procedure. Over time, the device activates and supports the regeneration of healthy cartilage, the key to unlocking true longevity for patients. The device has been tested and perfected in multiple pre-clinical trials, and it is being prepared for human clinical study in 2023.
🔗
Website
🔗
LinkedIn
âš¡
Nanochon has five positions available.

Description of Project

Nanochon has several key projects that a team could potentially work on:

  1. Developing a surgical tool: a critical need is the testing of a surgical tool to deliver the device. A working prototype exists, but it needs to be validated with clinicians, and improved upon. A team could discuss and even show the device to potential customers, to collect VOC data.
  2. Nanochon used in other joints: based on observed performance, we believe the Nanochon device and technology could be applied to may applications in the body. We would be interested in both customer discovery activity to identify these areas, and efforts to test the device in simulated or cadaveric environments. As an example, we are very interested in treating cartilage damage in ankles, so a team could interview ankle surgeons AND test the device in an ankle cadaver.
  3. Investigating foreign regulatory and reimbursement: Nanochon is very keyed into the US FDA and US market, but much could be done to define an international strategy. Specifically, to understand the regulatory requirements and paths to reimbursement in international markets, such as The EU, Canada, SE Asia etc.

Goals and Rationale for Project

In all cases, we are looking to address critical areas for Nancohon's long term success, which would otherwise distract from our immediate priorities.

Key Metrics and Deliverables

  1. Deliverables would be a VOC report, with at least 30 interviews, and proposed design elements or changes
  2. A report with at least 30 customer interviews, and potentially a test report with findings from cadaver test(s).
  3. A report at least detailing regulatory pathways and requirements in a minimum of 3 key international markets.

Ideal Competencies

Minimally invasive surgery, orthopedic surgery and sports medicine knowledge is a plus but not required

Nanochon in the News

BICO and Nanochon to develop 3D printed joint restoration implant

Home / Bioprinting /BICO and Nanochon to develop 3D printed joint restoration implant Biofabrication Bioprinting Medical Orthopedic Implants Regenerative Medicine Bioconvergence company BICO is partnering with Nanochon, a startup developing regenerative joint replacements. Under the terms of the deal, Nanochon will purchase $1.5 million worth of products and services from BICO's SCIENION to develop 3D printed regenerative joint implants.

BICO and Nanochon to develop 3D printed joint restoration implant
Startups to Watch: Nanochon - Washington Business Journal

District med-tech startup Nanochon LLC is shooting to close a $3.5 million seed round in January to fund the first human study of its product, a 3D-printed implant made with George Washington University-licensed technology that replaces lost or damaged cartilage as an alternative to replacement surgeries.

Startups to Watch: Nanochon - Washington Business Journal
BICO and Nanochon announce $1.5 million partnership to develop regenerative joint implants

3D bioprinting firm BICO has announced an initial $1.5 million contract manufacturing deal with regenerative joint replacement start-up Nanochon. The deal will see Nanochon purchase products and services worth $1.5 million from BICO's SCIENION company to develop its 3D printed regenerative joint implants, which the start-up claims will deliver faster recoveries for patients while reducing costs to health providers.

BICO and Nanochon announce $1.5 million partnership to develop regenerative joint implants